Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Danlu capsule + Huangkui capsule for granulomatous lobular mastitis (real-world)
ChiCTR2400083017Phase 4Not yet recruiting
- Sponsor
- Longhua Hospital Shanghai University of Traditional Chinese Medicine
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Danlu Capsule and huang kui capsule in Granulomatous lobular mastitis (GLM) (2 arms), sponsored by Longhua Hospital Shanghai University of Traditional Chinese Medicine. Primary endpoints: Breast specialist examination and Breast color ultrasound. Planned start Apr 2024; status: not yet recruiting.
02
Drugs
Danlu Capsulehuang kui capsule
03
Conditions
Granulomatous lobular mastitis (GLM)
Beyond the preview
Go deeper on ChiCTR2400083017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400083017.